WebOct 9, 2006 · Coumarin derivatives (warfarin, phenprocoumon, acenocoumarol) Several adverse skin manifestations associated with the use of oral anticoagulants, ranging from ecchymoses and purpura, hemorrhagic necrosis, maculopapular, vesicular, and urticarial eruptions to purple toes are known . The ... WebStart bivalirudin infusion at time when next dose of LMWH/SC agent is due Vitamin K Antagonists Warfarin heparin, argatroban, or bivalirudin infusion Stop warfarin Initiate …

Warfarin (Coumadin) UW Medicine Anticoagulation Services

WebVitamin K Antagonists: Warfarin (Coumadin®) o Warfarin may be held, or reduced, with INR correction in 2-5 days for MOST patients. Cause of elevated INR should be … WebJul 31, 2007 · These new parenteral anticoagulants (LMWH, bivalirudin, and fondaparinux) are effective and, because of their advantages over UFH, have replaced or are likely to replace UFH for many acute cardiac indications. As a result, the need for additional parenteral anticoagulants is less pressing than for new oral anticoagulants to replace … sap cps full form

DailyMed - ANGIOMAX- bivalirudin injection

WebAfter 3-5 days of co-therapy with warfarin, temporarily suspend the bivalirudin for 4 hours, then check the INR. If the INR is <2.0, restart the bivalirudin and consider warfarin … WebINR 1.5-1.7. Consider a booster dose of 1 ½ – 2 times daily maintenance dose. Consider resumption of prior maintenance dose if factor causing decreased INR is considered [e.g.: missed warfarin dose (s)] If a dosage adjustment is needed, increase maintenance dose by 5-15%. INR 2.0–2.3. Webuse warfarin) or if active or a history of warfarin-induced skin necrosis (do not use warfarin unless consulting Hematology or Vascular Medicine first). Contraindications for the use … short story in quotes or italics